NeuroPace Announces Pricing of Public Offering of $65 Million of Common Stock
NeuroPace expects to use approximately $49.5 million of the net proceeds from the offering to repurchase 5,270,845 shares held by NeuroPace’s significant stockholder, KCK Ltd., at $9.40 per share, ...
NeuroPace Announces Proposed Public Offering of $65 Million of Common Stock
NeuroPace expects to use a substantial portion of the proceeds from the public offering to repurchase all of the shares held by NeuroPace’s significant stockholder, KCK Ltd., at a price per share ...